title: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
authors.affiliation: University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, USA. Lesley.Arnold@uc.edu
authors.forename: Lesley M
authors.initials: LM
authors.lastname: Arnold
authors.forename: Yili
authors.initials: Y
authors.lastname: Lu
authors.forename: Leslie J
authors.initials: LJ
authors.lastname: Crofford
authors.forename: Madelaine
authors.initials: M
authors.lastname: Wohlreich
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Detke
authors.forename: Smriti
authors.initials: S
authors.lastname: Iyengar
authors.forename: David J
authors.initials: DJ
authors.lastname: Goldstein
mesh_terms: D015897:Comorbidity; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000453:epidemiology; D004311:Double-Blind Method; D000068736:Duloxetine Hydrochloride; D005260:Female; D005356:Fibromyalgia / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D014179:Neurotransmitter Uptake Inhibitors / Q000627:therapeutic use*; D012737:Sex Factors; D013876:Thiophenes / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014179:Neurotransmitter Uptake Inhibitors; D013876:Thiophenes; D000068736:Duloxetine Hydrochloride